May 19, 2020
Press Release

Genesis Healthcare appoints a President and nominates Directors

TOKYO, May 19th, 2020 — Genesis Healthcare Co. announces new leadership, appointing a President and additions to its Board of Directors.

Following a Shareholder Meeting and Board Meeting held on May 19th, 2020, Genesis Healthcare Co. announces the following appointments:

President and Representative Director:

Dr. Akihiro Sekine is appointed President and Representative Director of Genesis Healthcare Co. as of July 1st, 2020.

Dr. Sekine graduated in 1983 from Toho University School of Pharmaceutical Sciences, completing his master in 1985. A recognized expert in the genetic field in Japan, Dr. Sekine is currently a Professor PhD. at the Center for Preventive Medical Science of Chiba University. Prior to becoming Professor at Chiba University, Dr. Sekine has held positions at Riken Institute of Physical and Chemical Research (May 2000 – March 2006) and Graduate School of Medicine at Kyoto University (September 2006 – March 2010).

Matthew J. Burlage, currently interim Representative Director, will support in the transition and will remain as external Director to the Board of Directors once Dr. Sekine has been on-boarded.

Appointments and changes to the Board of Directors as of 19th of May 2020:

Appointment of Chairman:
Dr. Yoshinori Shirono is appointed Chairman of the Board of Directors, replacing David Baran, who will remain as external Director.

Dr. Shirono graduated from Keio University School of Medicine in 1988. After starting his medical career at Saiseikai Central Hospital as a general surgeon, Dr. Shirono worked in 1990 at the Oshiro Clinic and Japan Medical Laser Laboratory. In 1995, he founded the Shirono Clinic and skin-care laboratory specializing in cosmetic dermatology. Subsequently, Dr. Shirono founded Dr. Ci:Labo in 1999 and he is currently Founder of Ci:z Holdings Co., Ltd.

Appointments to the Board of Directors:
Mutsuki Takano, currently Chief Financial Officer of Genesis Healthcare Co. is appointed to the Board of Directors.

Hiroshi Takasawa is appointed to the Board of Directors. Hiroshi Takasawa is currently Managing Executive Officer of Rakuten Inc. and CEO of Rakuten Asia and President of Rakuten Investment and Incubation Company.

Management appointment:
Yoshisuke Yamada, currently Chief Operating Officer (COO) and Board Director, is appointed Managing Director of Genesis Healthcare Co.

For media enquiries, please contact:
Vox Global Japan (public relations agent)
Rie Sugiyama
Tel: +81 (0)80 2042 2852